Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study

doi:10.3748/wjg.v22.i16.4191

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8604)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-3) series.

Item

Count

PDF

629

WORD

364

HTML

4164

Figures (1-4)

337

Tables (1-3)

232

Sum=5726

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1070

Download

1807

Sum=2877

Apr 28, 2016 (publication date) through Jan 30, 2025

Times Cited of This Article

Times Cited (28)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 28, 2016; 22(16): 4191-4200
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4191

Table 1 Subject demographics of the Bangladeshi study cohort

Group	n	Age (yr), median (range)	M:F (%male)	Etiology, n	HBeAg positive	Height (cm), median (range)	Weight (kg), median (range)	BMI (kg/m²), median (range)
CTR	7	37 (24-46)	7:0 (100%)	NA	NA	170 (152-173)	65 (54-85)	26.0 (18.7-29.4)
CHB	46	27 (15-45)	40:6 (87%)	HBV (100%)	27	166 (147- 180)	55 (35-79)	20.6 (13.9-26.6)
CHB	46	27 (15-45)	40:6 (87%)	HBV (100%)	(-59%)	166 (147- 180)	55 (35-79)	20.6 (13.9-26.6)
CIR	47	42 (15-67)	39:8 (83%)	HBV (98%)	21	165 (142–175)	58 (42-82)	21.9 (14.9-29.3)
CIR	47	42 (15-67)	39:8 (83%)	Cryptogenic HBV (2%)	(-45%)	165 (142–175)	58 (42-82)	21.9 (14.9-29.3)
HCC	42	48 (27-90)	38:3 (90%)	HBV (93%)	15	162 (145-180)	48 (38-75)	18.3 (12.3-25.2)
				HCV (2%)	(-36%)
				Cryptogenic (5%)

CTR: Healthy controls; CHB: Chronic hepatitis-B related liver disease; CIR: Cirrhosis; HCC: Hepatocellular carcinoma; NA: Unavailable; BMI: Body mass index.

Citation: Cox IJ, Aliev AE, Crossey MM, Dawood M, Al-Mahtab M, Akbar SM, Rahman S, Riva A, Williams R, Taylor-Robinson SD. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study. World J Gastroenterol 2016; 22(16): 4191-4200
URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4191.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i16.4191